Estimands: discussion points from the PSI estimands and sensitivity expert group.
- Published in:
- Pharmaceutical Statistics, 2017, v. 16, n. 1, p. 6, doi. 10.1002/pst.1745
- By:
- Publication type:
- Article
Works by Fletcher, Chrissie
Results: 4
1
2
Utility values in health technology assessments: a statistician's perspective.
- Published in:
- Pharmaceutical Statistics, 2014, v. 13, n. 3, p. 184, doi. 10.1002/pst.1616
- By:
- Publication type:
- Article
3
Multiplicity: discussion points from the Statisticians in the Pharmaceutical Industry multiplicity expert group.
- Published in:
- Pharmaceutical Statistics, 2013, v. 12, n. 5, p. 255, doi. 10.1002/pst.1584
- By:
- Publication type:
- Article
4
Statistical approaches for conducting network meta-analysis in drug development.
- Published in:
- Pharmaceutical Statistics, 2011, v. 10, n. 6, p. 523, doi. 10.1002/pst.533
- By:
- Publication type:
- Article